Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Plasma cell 1Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 27Leukemia 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia, Myelomonocytic, Acute 6Leukemia, Monocytic, Acute 6Leukemia, Megakaryoblastic, Acute 6Leukemia, Erythroblastic, Acute 6Myelodysplastic Syndromes 5Anemia, Refractory, with Excess of Blasts 5Lymphoma, Non-Hodgkin 4Lymphoma, Follicular 4Lymphoma 4Leukemia, Promyelocytic, Acute 4Leukemia, Myelomonocytic, Chronic 4Neoplasms, Plasma Cell 3Multiple Myeloma 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myeloid, Chronic-Phase 3Neutropenia 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Lymphocytic, Chronic, B-Cell 2Congenital Abnormalities 2Anemia, Refractory 2Sarcoma, Synovial 1Sarcoma 1Rhabdomyosarcoma 1Myeloproliferative Disorders 1

Interventions

Cyclophosphamide 16Vincristine 12Doxorubicin 11Radiotherapy 10Etoposide 9Prednisone 8Peripheral Blood Stem Cell Transplantation 8VAP-cyclo protocol 6Filgrastim 6Rituximab 5Mitoxantrone 5Melphalan 5Cytarabine 5Carmustine 4Bleomycin 4Prednisolone 3Methylprednisolone 3Methotrexate 3Idarubicin 3liposomal amphotericin B 2aldesleukin 2Therapeutics 2Psychiatric Rehabilitation 2Levofloxacin 2Leucovorin 2Interferon-alpha 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Epoetin Alfa 2Early Intervention, Educational 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, Large-Cell, Immunoblastic × Idarubicin × Clear all
NCT00002835 2018-11-15

Combination Chemotherapy in Treating Patients With Lymphoma

M.D. Anderson Cancer Center

Phase 3 Completed
116 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

NCT00002565 2018-11-14

Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma

M.D. Anderson Cancer Center

Phase 3 Completed
61 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

NCT00002989 2009-02-09

Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 3 Unknown
207 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡